Androgen Insensitivity Syndrome (AIS) is a condition that affects sexual development before birth and during puberty. It is caused by mutations in the AR gene, which is essential for directing male sexual development. This condition is part of a spectrum, with partial androgen insensitivity syndrome (PAIS) being one of its forms. PAIS can result in a wide range of genital ambiguity and can affect individuals differently, depending on the degree of insensitivity to androgens, the male sex hormones. Furthermore, research has indicated a potential link between mutations in the AR gene and an increased risk of breast cancer, making genetic testing an important tool for individuals with PAIS and their families. DNA Labs UAE offers a comprehensive AR Gene Androgen Insensitivity Partial with or without Breast Cancer Genetic Test, priced at 4400 AED, designed to provide crucial insights into these genetic factors.
Understanding Partial Androgen Insensitivity Syndrome (PAIS)
Partial Androgen Insensitivity Syndrome is a genetic condition that results from mutations in the AR gene. These mutations impair the body’s ability to respond properly to androgens, which are hormones responsible for male sexual development. As a result, individuals with PAIS may have a range of physical characteristics that can vary significantly from person to person. The severity of the condition is often classified based on the degree of genital ambiguity, which can range from mild to severe.
Symptoms of Partial Androgen Insensitivity Syndrome
The symptoms of PAIS can vary widely but typically include a mixture of physical characteristics associated with both male and female sexual development. Some common symptoms include:
- Ambiguous genitalia at birth
- Partially descended testes
- A reduced ability to grow facial and body hair
- Development of breast tissue during puberty
- A female-typical or mildly masculinized body shape
It’s important to note that the severity and combination of these symptoms can vary widely among individuals with PAIS.
The Link Between AR Gene Mutations and Breast Cancer
Recent studies have suggested a potential link between mutations in the AR gene and an increased risk of breast cancer. This connection is particularly relevant for individuals with PAIS, as they may carry mutations that not only affect their sexual development but also influence their risk of developing breast cancer. Genetic testing can play a crucial role in identifying these mutations, enabling individuals and their healthcare providers to make informed decisions about monitoring and managing their health.
AR Gene Androgen Insensitivity Partial with or without Breast Cancer Genetic Test
DNA Labs UAE offers a comprehensive genetic test designed to identify mutations in the AR gene associated with partial androgen insensitivity syndrome and assess the risk of breast cancer. This test is priced at 4400 AED and is an invaluable tool for individuals with PAIS or a family history of the condition. By understanding their genetic makeup, individuals can take proactive steps towards managing their health, including regular monitoring for signs of breast cancer if their risk is elevated.
Why Choose DNA Labs UAE for Your Genetic Testing Needs?
DNA Labs UAE is a leading provider of genetic testing services, offering a wide range of tests designed to provide individuals with valuable insights into their health and genetic predispositions. Our AR Gene Androgen Insensitivity Partial with or without Breast Cancer Genetic Test is conducted by experienced professionals using state-of-the-art technology to ensure accurate and reliable results. Additionally, our team is committed to providing personalized support throughout the testing process, helping you understand your results and their implications for your health.
For more information about the AR Gene Androgen Insensitivity Partial with or without Breast Cancer Genetic Test and to schedule your test, please visit our website at DNA Labs UAE.
